Carbamazepine
| Category | Biochemistry |
|---|---|
| Test background |
Carbamezepine is indicated for the treatment of partial and secondary generalised tonic-clonic seizures, primary generalised tonic-clonic seizures; trigeminal neuralgia and prophylaxis of bipolar disorder unresponsive to lithium. |
| Clinical Indications |
Therapeutic drug monitoring |
| Reference range | 4-12 mg/L |
| Sample & container required | SST (gold top) or serum (red top) |
| Sample volume | 0.5 mL pre-dose trough sample |
| Turnaround time | 2 days |